Genomic Profiling: Interplay between clinical epidemiology, bioinformatics and biostatistics

Methods of Information in Medicine

Volumn 44, Issue 3, 2005, Pages 454-460

  Mansmann, Ulrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cancer; Clinical epidemiology; Computational statistics; Experimental design; Microarray profiling

Indexed keywords

ARTICLE; BREAST CANCER; DATA ANALYSIS; DNA MICROARRAY; EXPERIMENTAL DESIGN; GENE EXPRESSION PROFILING; GENOMICS; HUMAN; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

EID: 22944446741     PISSN: 00261270     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1633993     Document Type: Article

References (29)

1. Simon R, Altman D. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994; 69: 979-85.
2. van't Veer L, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, van de Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-6.
3. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999-2009.
4. Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM, West M, Nevins JR, Huang AT. Gene expression predictors of breast cancer outcomes. The Lancet 2003; 361: 1590-6.
5. Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, O'Connell P. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. The Lancet 2003; 362: 362-9.
6. Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. The Lancet 2001; 357: 1191-4.
7. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, for the QUORUM Group. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUORUM Statement. The Lancet 1999; 354: 1896-1900.
8. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC; STARD group. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem Lab Med 2003; 41: 68-73.
9. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia: Lippincott; 1997.
10. Tibshirani RJ, Efron B. Pre-validation and inference in microarrays. Statistical Applications in Genetics and Molecular Biology 2002; 1(1).
11. Cox DR. Planning of experiments. New York: Wiley & Sons; 1958.
12. Brenton JD, Caldas C (2003) Predictive cancer genomics - what do we need? The Lancet 2003; 362: 340-1.
13. Faneyte IF et al. Breast cancer response to neo-adjuvant chemotherapy: predictive markers and relation with outcome. Br J Cancer 2003; 88: 406-12.
14. Markowetz F, Spang R. Molecular Diagnosis: Classification, Model Selection and Performance Evaluation. Methods Inf Med 2005; 44: 438-43 (this issue).
15. Ambroise C, McLachlan GJ. Selection bias in gene extraction on the basis of microarray gene expression data. Proc Natl Acad Sci 2003; 99: 6562-6.
16. Pepe MS, Longton G, Anderson GL, Schummer M Selecting differentially expressed genes from microarray experiments. Biometrics 2003; 59: 133-42.
17. Ruschhaupt M, Huber W, Poustka A, Mansmann U. A Compendium to Ensure Computational Reproducibility in High-Dimensional Classification Tasks. Statistical Applications in Genetics and Molecular Biology 2004; 3 (1): article 37. http://www.bepress.com/sagmb/vol3/iss1/art37
18. http://www.geneontology.org
19. Ramaswamy S, Perou CM. DNA microarray in breast cancer: The promise of personalized medicine. The Lancet 2003; 361: 1576-7.
20. Breit S., Nees M., Schaefer U, Pfoersich M, Hagemeier C, Muckenthaler M, Kulozik A. Impact of pre-analytic handling on bone marrow mRNA gene expression. BJH 2004; 126: 231-43.
21. Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 2004; 20: 93-9.
22. Mansmann U, Meister R. Testing differential gene expression in functional groups: Goeman's global test versus an ANCOVA approach. Methods Inf Med 2005; 44: 449-53 (this issue).
23. Schmoor C, Sauerbrei W, Schumacher M. Sample size considerations for the evaluation of prognostic factors in survival analysis. Stat Med 2000; 19: 441-52.
24. Leisch, F. and Rossini, A. J. Reproducible Statistical research. Chance 2003; 16: 41-5.
25. Sawitzki, G. Keeping Statistics Alive in Documents. Computational Statistics 2002; 17: 65-88.
26. http://www.biometrie.uni-heidelberg.de/mb/SAS makros.htm
27. www.r-project.org
28. www.bioconductor.org
29. Bogardus ST Jr, Concato J, Feinstein AR. Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA 1999; 28: 1919-26.